Pallevi Srivastva, Ph.D.

Pallevi Srivastva, Ph.D. has a diverse and extensive work experience in the field of biotechnology and research. Pallevi most recently held the position of Head of Process Development and Scaling Operations at Wildtype since July 2021. Prior to that, they served as the Head of Cell Culture Medium Formulation & Lab Scale Process Development at the same company from October 2019 to July 2021. Before joining Wildtype, Pallevi worked as a Scientist in Cell Culture Medium Formulation & Lab Scale Process Development from January 2019 to October 2019.

Pallevi's previous experience includes working as a Postdoctoral Scientist at Agilent Technologies from November 2016 to November 2018. In this role, they focused on developing new technologies to enhance the performance of bio-analytical platforms for cell-based applications using droplet microfluidics. Pallevi also worked on sample preparation protocols for cellular analysis using mass spectrometry.

Prior to their time at Agilent Technologies, Pallevi served as a Global Scholar and Life Science Consultant at PreScouter, Inc. from February 2016 to December 2016. In this role, they provided business solutions to corporate leaders, conducted due diligence on specific companies, and performed prior art searches to propose solutions and recommend potential partners.

Pallevi's earlier experience includes working as a Technology Transfer Intern at UT Dallas, Office of Technology Commercialization from January 2016 to August 2016. In this role, they assessed and analyzed technologies emerging from UTD's researchers, conducted prior art searches, and assisted with patent filing decisions. Pallevi also worked as a PhD candidate and Graduate Research Assistant at UT Dallas, where they developed mass spectrometry methods and conducted experiments to identify cancer-specific biochemical pathways and develop therapeutic strategies against non-small cell lung cancer (NSCLC).

Pallevi's work experience also includes a research internship at Panacea Biotec Ltd in 2006.

Overall, Pallevi Srivastva, Ph.D. has amassed valuable expertise in process development, formulation, research, and business consulting within the biotechnology industry.

Pallevi Srivastva, Ph.D. pursued their education in a progressive manner, obtaining degrees and certifications along the way. Pallevi started their educational journey at Bundelkhand University from 2003 to 2007, where they earned a Bachelor of Technology (BTech) in Biotechnology. Building on their undergraduate studies, they then pursued a Master of Science (MS) in Biotechnology from The University of Texas at Dallas, which they completed from 2007 to 2009. Eventually, Pallevi Srivastva went on to complete their education at The University of Texas at Dallas, where they earned a Doctor of Philosophy (PhD) in Molecular Biology from 2010 to 2016. This signifies their commitment to expanding their knowledge and expertise in their chosen field.

In addition to their formal education, Pallevi Srivastva has also acquired additional certifications to enhance their skill set. In June 2018, they obtained a certification in Small Molecule Drug Discovery & Development. Pallevi further enhanced their qualifications by obtaining a certification in Q-TOF LC-MS Techniques & Operation for Small Molecules in December 2017. These certifications demonstrate their dedication to staying updated with the latest advancements in their field and further highlight their commitment to professional growth.